| Trial ID: | L5571 |
| Source ID: | NCT01588587
|
| Associated Drug: |
Sitagliptin
|
| Title: |
DPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Sitagliptin|DRUG: Alogliptin|DRUG: Vildagliptin
|
| Outcome Measures: |
Primary: Frequency of cancers, Each one year within 5 years | Secondary: AGE concentration, Serum AGE is measured using ELISA at the laboratory of Department pf Pathophysiology and Therapeutics of Diabetes Vascular Complications, Kurume University, which requre as 0.75 ml of serum in each patient., Before and each one year within 5 years|Receptor for AGE concentration, Serum receptor for AGE is measured using ELISA at the laboratory of Department pf Pathophysiology and Therapeutics of Diabetes Vascular Complications, Kurume University, which requre as 0.75 ml of serum in each patient, Before and each one year within 5 years
|
| Sponsor/Collaborators: |
Sponsor: Nagaoka Red Cross Hospital | Collaborators: Kurume University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
500
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2012-10
|
| Completion Date: |
2017-12
|
| Results First Posted: |
|
| Last Update Posted: |
2012-10-19
|
| Locations: |
Kurume University, Kurume, Fukuoka, 830-0111, Japan|Nagaoka Red Cross Hospital, Nagaoka, Niigata, 940-2085, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01588587
|
